16-50697246-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001370466.1(NOD2):​c.-8-2242G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000142 in 1,404,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

NOD2
NM_001370466.1 intron

Scores

3
1
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.229

Publications

0 publications found
Variant links:
Genes affected
NOD2 (HGNC:5331): (nucleotide binding oligomerization domain containing 2) This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
NOD2 Gene-Disease associations (from GenCC):
  • Blau syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, G2P, Illumina, Labcorp Genetics (formerly Invitae)
  • inflammatory bowel disease 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.855

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOD2NM_001370466.1 linkc.-8-2242G>A intron_variant Intron 1 of 11 ENST00000647318.2 NP_001357395.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOD2ENST00000647318.2 linkc.-8-2242G>A intron_variant Intron 1 of 11 NM_001370466.1 ENSP00000495993.1 Q9HC29-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000142
AC:
2
AN:
1404012
Hom.:
0
Cov.:
31
AF XY:
0.00000289
AC XY:
2
AN XY:
693048
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
31860
American (AMR)
AF:
0.00
AC:
0
AN:
36384
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25218
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36218
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79462
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5680
European-Non Finnish (NFE)
AF:
0.00000185
AC:
2
AN:
1081366
Other (OTH)
AF:
0.00
AC:
0
AN:
58202
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.002339), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.350
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autoinflammatory syndrome Uncertain:1
Apr 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Benign
-0.33
CADD
Benign
6.1
DANN
Benign
0.89
DEOGEN2
Benign
0.073
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.058
N
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.041
D
MetaRNN
Pathogenic
0.86
D
MetaSVM
Benign
-0.91
T
PhyloP100
0.23
PROVEAN
Benign
-0.16
N
REVEL
Benign
0.17
Sift
Pathogenic
0.0
D
Polyphen
0.0
B
Vest4
0.28
MutPred
0.99
Gain of catalytic residue at M1 (P = 0.0461);
MVP
0.73
ClinPred
0.14
T
GERP RS
0.77
PromoterAI
0.0067
Neutral
Varity_R
0.84
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr16-50731157; API